Leonteq Securities’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-30,000
Closed -$72K – 1346
2026
Q2
$72K Hold
30,000
– – ﹤0.01% 742
2026
Q1
$46.8K Hold
30,000
– – ﹤0.01% 866
2025
Q4
$34.5K Buy
+30,000
New +$41.2K ﹤0.01% 1015

Other funds holding LXRX

Leonteq Securities's LXRX Position: Q3 2026 in Review

Leonteq Securities sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2026, closing a stake of 30,000 shares — an estimated $72K sold.

Leonteq Securities first reported a position in LXRX in Q4 2025 and held it in 3 quarters. The position peaked at $72K in Q2 2026. 156 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.

  • Leonteq Securities reported no remaining Lexicon Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Leonteq Securities sold 30,000 Lexicon Pharmaceuticals shares in Q3 2026, an estimated $72K.
  • Leonteq Securities first reported a position in Lexicon Pharmaceuticals in Q4 2025 and held it in 3 quarters.
  • Leonteq Securities's Lexicon Pharmaceuticals position peaked at $72K in Q2 2026.
  • 156 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.